These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
609 related items for PubMed ID: 17684032
1. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis. Peak AS, Sheller A. Ann Pharmacother; 2007 Sep; 41(9):1481-5. PubMed ID: 17684032 [Abstract] [Full Text] [Related]
2. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature. Lim YL, Lee HY, Low SC, Chan LP, Goh NS, Pang SM. Clin Exp Dermatol; 2007 Jul; 32(4):353-8. PubMed ID: 17433041 [Abstract] [Full Text] [Related]
3. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure. Grobner T, Prischl FC. Semin Dial; 2008 Jul; 21(2):135-9. PubMed ID: 18226001 [Abstract] [Full Text] [Related]
4. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness. Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P. J Nephrol; 2008 Jul; 21(3):324-36. PubMed ID: 18587720 [Abstract] [Full Text] [Related]
5. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Broome DR. Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138 [Abstract] [Full Text] [Related]
6. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. Wiginton CD, Kelly B, Oto A, Jesse M, Aristimuno P, Ernst R, Chaljub G. AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456 [Abstract] [Full Text] [Related]
7. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study. Kallen AJ, Jhung MA, Cheng S, Hess T, Turabelidze G, Abramova L, Arduino M, Guarner J, Pollack B, Saab G, Patel PR. Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784 [Abstract] [Full Text] [Related]
8. Nephrogenic systemic fibrosis--implications for nephrologists. Saab G, Abu-Alfa A. Eur J Radiol; 2008 May; 66(2):208-12. PubMed ID: 18342470 [Abstract] [Full Text] [Related]
13. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media. Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ. Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279 [Abstract] [Full Text] [Related]
15. Nephrogenic systemic fibrosis and its impact on abdominal imaging. Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN. Radiographics; 2009 Oct; 29(6):1565-74. PubMed ID: 19959508 [Abstract] [Full Text] [Related]
16. Nephrogenic systemic fibrosis: more questions and some answers. Morcos SK, Thomsen HS. Nephron Clin Pract; 2008 Oct; 110(1):c24-31; discussion c32. PubMed ID: 18688172 [Abstract] [Full Text] [Related]
17. Nephrogenic systemic fibrosis: center case review. Lauenstein TC, Salman K, Morreira R, Tata S, Tudorascu D, Baramidze G, Singh-Parker S, Martin DR. J Magn Reson Imaging; 2007 Nov; 26(5):1198-203. PubMed ID: 17969162 [Abstract] [Full Text] [Related]
18. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Deo A, Fogel M, Cowper SE. Clin J Am Soc Nephrol; 2007 Mar; 2(2):264-7. PubMed ID: 17699423 [Abstract] [Full Text] [Related]
20. How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States. Thomsen HS. Radiol Clin North Am; 2009 Sep; 47(5):871-5, vii. PubMed ID: 19744601 [Abstract] [Full Text] [Related] Page: [Next] [New Search]